» Articles » PMID: 38871437

Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force

Abstract

This ISPOR Good Practices report provides a framework for assessing the suitability of electronic health records data for use in health technology assessments (HTAs). Although electronic health record (EHR) data can fill evidence gaps and improve decisions, several important limitations can affect its validity and relevance. The ISPOR framework includes 2 components: data delineation and data fitness for purpose. Data delineation provides a complete understanding of the data and an assessment of its trustworthiness by describing (1) data characteristics; (2) data provenance; and (3) data governance. Fitness for purpose comprises (1) data reliability items, ie, how accurate and complete the estimates are for answering the question at hand and (2) data relevance items, which assess how well the data are suited to answer the particular question from a decision-making perspective. The report includes a checklist specific to EHR data reporting: the ISPOR SUITABILITY Checklist. It also provides recommendations for HTA agencies and policy makers to improve the use of EHR-derived data over time. The report concludes with a discussion of limitations and future directions in the field, including the potential impact from the substantial and rapid advances in the diffusion and capabilities of large language models and generative artificial intelligence. The report's immediate audiences are HTA evidence developers and users. We anticipate that it will also be useful to other stakeholders, particularly regulators and manufacturers, in the future.

Citing Articles

Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report.

Fleurence R, Bian J, Wang X, Xu H, Dawoud D, Higashi M Value Health. 2024; 28(2):175-183.

PMID: 39536966 PMC: 11786987. DOI: 10.1016/j.jval.2024.10.3846.


Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases.

Timbie J, Kim A, Baker L, Li R, Concannon T J Comp Eff Res. 2024; 13(9):e240078.

PMID: 39150225 PMC: 11367563. DOI: 10.57264/cer-2024-0078.

References
1.
Reges O, Weinberg H, Hoshen M, Greenland P, Rayyan-Assi H, Tsadok M . Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study. Clin Epidemiol. 2020; 12:477-483. PMC: 7246307. DOI: 10.2147/CLEP.S230677. View

2.
Ball R, Robb M, Anderson S, Dal Pan G . The FDA's sentinel initiative--A comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2015; 99(3):265-8. DOI: 10.1002/cpt.320. View

3.
Fleurence R, Shuren J . Advances in the Use of Real-World Evidence for Medical Devices: An Update From the National Evaluation System for Health Technology. Clin Pharmacol Ther. 2019; 106(1):30-33. PMC: 6617981. DOI: 10.1002/cpt.1380. View

4.
Estevez M, Benedum C, Jiang C, Cohen A, Phadke S, Sarkar S . Considerations for the Use of Machine Learning Extracted Real-World Data to Support Evidence Generation: A Research-Centric Evaluation Framework. Cancers (Basel). 2022; 14(13). PMC: 9264846. DOI: 10.3390/cancers14133063. View

5.
Kahn M, Callahan T, Barnard J, Bauck A, Brown J, Davidson B . A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMS (Wash DC). 2016; 4(1):1244. PMC: 5051581. DOI: 10.13063/2327-9214.1244. View